Results 21 to 30 of about 2,749,598 (311)

Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab [PDF]

open access: yes, 2015
Background: The aim of our study was to evaluate whether a panel of biomarkers, prospectively analysed might be able to predict patients' clinical outcome more accurately than RAS status alone.
Abouelkhair, KM   +10 more
core   +3 more sources

Study on clinical profile and antibiotic sensitivity pattern of enteric fever patients in a tertiary care hospital of East India

open access: yesAsian Journal of Medical Sciences, 2022
Background: Enteric fever is a global health problem which is endemic in the Indian subcontinent. With the changing pattern of clinical presentation and antibiotic sensitivity, physicians are facing a challenge to treat the disease in day-to-day practice.
Pradeep Chakraborty   +3 more
doaj   +1 more source

CLINICAL PROFILES [PDF]

open access: yesBlood, 1968
Abstract Experience by many observers in the last few years has shown that intravenously administered iron dextran is a useful and safe agent in the management of iron-deficiency anemia. The conscientious physician, who has diagnosed iron deficiency by the absence of hemosiderin in marrow or by the characteristic serum values for iron ...
openaire   +3 more sources

Efficacy and safety of TDF/FTC-containing first-line HAART in clinical practice – 2-year data from the German Outpatient Cohort [PDF]

open access: yes, 2008
Poster presentation: Purpose of the study First-line HAART with tenofovir DF (TDF) and FTC in pivotal trials has been associated with high efficacy and good tolerability.
Braun, Patrick   +8 more
core   +1 more source

Celecoxib clinical profile [PDF]

open access: yesRheumatology, 2000
Celecoxib is the first COX-2-specific inhibitor approved for relief of the signs and symptoms of osteoarthritis (OA) and rheumatoid arthritis (RA), as well as for treatment of familial adenomatous polyposis. For both OA and RA, celecoxib has been shown to be significantly superior in efficacy to placebo and similar in efficacy to traditional non ...
openaire   +2 more sources

Demographic profile, clinical features, imaging and outcomes in patients with traumatic brain injury presenting to emergency room

open access: yesJournal of Clinical and Scientific Research, 2019
Background: Traumatic brain injury (TBI) accounts for one-quarter to one-third of all accidental deaths, and for two-thirds of trauma deaths in hospitals.
M R Kirankumar   +5 more
doaj   +1 more source

Varied profile in acute coronary syndrome: One size does not fit all

open access: yesAPIK Journal of Internal Medicine, 2022
Objective: The objective was to study the clinical profiles of patients undergoing coronary angiography (CAG). Setting and Design: It was a cross-sectional retrospective study of 207 patients who have undergone CAG at B and M Cardiac Centre, Shree ...
Chetsi Shah   +3 more
doaj   +1 more source

Clinical profile and atypical manifestation of dengue fever cases between 2011 and 2018 in Chennai, India

open access: yesJournal of Family Medicine and Primary Care, 2020
Introduction: Dengue fever is a common mosquito-borne viral disease which has reached alarming size in the past few years. It is endemic in more than 100 countries and significant differences were found in clinical profile and atypical manifestation. Aim
Kamalraj Mohan   +12 more
doaj   +1 more source

Efficacy of Antibody Cocktail Drug in COVID-19 Positive Patients: A Retrospective Single-centered Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2023
Introduction: Neutralising monoclonal antibodies (mABs) have been proposed and developed for the treatment of Coronavirus Disease-2019 (COVID-19) patients with mild to moderate diseases and to prevent further progression.
Manoranjan Dash   +5 more
doaj   +1 more source

Ustekinumab for the treatment of psoriatic arthritis: an update. [PDF]

open access: yes, 2014
Psoriatic arthritis occurs in 30% of psoriasis patients, and the treatment can be challenging in some patients. Recently, the US Food and Drug Administration approved ustekinumab, a fully human monoclonal antibody, for the management of psoriatic ...
Davari, Parastoo   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy